Home > Publications > List of Publications
List of Publications

The Autism Tissue Program (ATP) is proud to provide the following partial list of publications in peer reviewed scientific journals that were made possibleby the efforts of this program.  This list, and the success of this program, is resultant of the altruism of individuals and their families, in giving the Gift of Hope, and donating brain tissue to further our understanding of autism.  Without the partnership of these families with the ATP, this field of science and our understanding of autism would falter, and much of this research might never have occurred. 

Scientific articles 

  1. Sarachana T, Xu M, Wu R-C, and VW Hu. Sex hormones in autism: Androgens and estrogens differentially and reciprocally regulate RORA, a novel candidate gene for autism. 2011 PLoS ONE In Press 
  2. Azmitia EC, Singh JS and PM Whitaker-Azmitia. 2011. Increased Serotonin Axons (Immunoreactive to 5-HT Transporter) in Postmortem Brains from Young Autism Donors. Neuropharmacology; In press. Ms. Ref. No.: NEUROPHARM-D-10-00385R1 
  3. Azmitia EC, Singh JS, Hou XP and J Wegiel. 2011. Dystrophic Serotonin Axons in Postmortem Brains from Young Autism Patients. The Anatomical Record; In press. 
  4. Wintle RF, Lionel AC, Hu P, Ginsberg SD, Pinto D, Thiruvahindrapduram B, Wei J, Marshall CR, Pickett J, Cook EH, Scherer SWA genotype resource for postmortem brain samples from the autism tissue program.  Autism Res. 2011 Jan 19. doi: 10.1002/aur.173. [Epub ahead of print].  
  5. Randy J. Kulesza Jr., Richard Lukose and Lisa Veith Stevens. Malformation of the human superior olive in autistic spectrum disorders. 2011. Brain Research 1367:360–371. 
  6. Schumann, CM and CW Nordahl. Bridging the gap between MRI and postmortem research in autism. Brain Res. (2010), doi:10.1016/j.brainres.2010.09.061 
  7. Carla Lintas, Laura Altieri, Federica Lombardi, Roberto Sacco and Antonio M. Persico.   Association of autism with polyomavirus infection in postmortem brains. Journal of NeuroVirology, 16: 141–149, 2010. 
  8. Basilis Zikopoulos and Helen Barbas. Changes in Prefrontal Axons May Disrupt the Network in Autism. The Journal of Neuroscience. 2010, 30(44):14595-14609.  
  9. Santos M, Uppal N, Butti C, Wicinski B, Schmeidler J, Giannakopoulos P, Heinsen H, Schmitz C, Hof PRvon Economo neurons in autism: A stereologic study of the frontoinsular cortex in children. Brain Res. 2010 Aug 27. [Epub ahead of print] 
  10. Adrian L Oblak, Ph.D.; Terrell T Gibbs, Ph.D.; Gene J Blatt, Ph.D. Reduced GABAA receptors and benzodiazepine binding sites in the posterior cingulate cortex and fusiform gyrus in autism. Brain Res. 2010 Sep 18. [Epub ahead of print] 
  11. John T. Morgan, Gursharan Chana, Carlos A. Pardo, Cristian Achim, Katerina Semendeferi,
    1. Jody Buckwalter, Eric Courchesne, and Ian P. Everall. 2010. Microglial Activation and Increased Microglial Density Observed in the Dorsolateral Prefrontal Cortex in
    2. Autism. Biol Psychiatry 2010;68:368–376. 
  12. Hsien-Sung Huang, Iris Cheung, and Schahram Akbarian. 2010. RPP25 is Developmentally Regulated in Prefrontal Cortex and Expressed at Decreased Levels in Autism Spectrum Disorder. Autism Research 3: 1–9. 
  13. Adrian Oblak, TT Gibbs and GT Blatt. Decreased GABA(B) Receptors in the Cingulate Cortex and Fusiform Gyrus in Autism.  J Neurochem. 2010 Jun 12.  
  14.  Palmieri L and Persico AM. 2010. Mitochondrial dysfunction in autism spectrum disorders: Cause or effect? Biochem Biophys Acta. 2010;1797(6-7):1130-1137. 
  15. Nguyen, A., Rauch, T.A., Pfeifer, G.P., and Hu, V.W. (2010) Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain. FASEB J., Published online Apr. 7, 2010. http://www.faseb.org;   doi: 10.1096/fj.10-154484 
  16. Sarachana, T., Zhou, R., Chen, G., Manji, H.K., and Hu, V.W. (2010) Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders (ASD) by microRNA expression profiling of lymphoblastoid cell lines. Genome Medicine, Published online Apr. 7, 2010. http://genomemedicine.com/content/2/4/32 
  17. Wegiel J, Kuchna I, Nowicki K, Imaki H, Wegiel J, Marchi E, Ma SY, Chauhan A,
    1. Chauhan V, Bobrowicz TW, de Leon M, Louis LA, Cohen IL, London E, Brown WT,
    2. Wisniewski T. 2010. The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathol. Jun;119(6):755-70. 
  18. Wegiel J, Wisniewski T, Chauhan A (2010) Type, topography and sequelae of neuropathological changes shaping clinical phenotype of autism. In: Chauhan A, Chauhan V, Brown WT et al (eds) Autism: oxidative stress, inflammation, and immune abnormalities. Taylor & Francis/CRC Press, Boca Raton, FL, pp 1–34. 
  19. Marissa Leigh Simms, Thomas L. Kempe, Clare M. Timbie, Margaret L. Bauman and Gene J. Blatt. The anterior cingulate cortex in autism: heterogeneity of qualitative and quantitative cytoarchitectonic features suggests possible subgroups. Acta Neuropathologica Online Issue Volume 118, Number 5 / November, 2009. 
  20. Jeffrey J. Hutsler & Hong Zhang. 2009.   Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Research Nov 5. [Epub ahead of print]. 
  21. Yip J, Soghomonian JJ, Blatt GJ. 2009. Decreased GAD65 mRNA levels in select subpopulations of neurons in the cerebellar dentate nuclei in autism: an in situ hybridization study. Autism Res. 2009 Feb;2(1):50-9. 
  22. Karen M. Weidenheim, Dennis W. Dickson & Isabelle Rapin. 2009. Neuropathology of Cockayne syndrome: Evidence for impaired development, premature aging, and neurodegeneration Mechanisms of Ageing and Development 130:619–636. 
  23. Simon G Gregory, Jessica J Connelly, Aaron J Towers, Jessica Johnson, Dhani Biscocho, 
    1. Christina A Markunas, Carla Lintas, Ruth K Abramson, Harry H Wright, Peter Ellis, Cordelia F Langford, Gordon Worley, G Robert Delong, Susan K Murphy, Michael L Cuccaro, Antonello Persico & Margaret A Pericak-Vance. 2009. Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Medicine 7:62. 
  24. L. A. Weiss, D.E. Arking, the Gene Discovery Project of Johns Hopkins & the Autism Consortium, MJ Daly and A. Chakravarti A. 2009. A genome-wide linkage and association scan reveals novel loci for autism. Nature Oct 8;461(7265):802-8. 
  25. S. Hossein Fatemi, Timothy D. Folsom, Teri J. Reutiman & Paul D. Thuras. 2009. Expression of GABAB Receptors Is Altered in Brains of Subjects with Autism. Cerebellum 8:64–69. 
  26. S. Hossein Fatemi, Teri J. Reutiman, Timothy D. Folsom and Paul D. Thuras. 2009. GABAA Receptor Downregulation in Brains of Subjects with Autism. J Autism Dev Disord 39:223–230. 
  27. Oblak A, Gibbs TT, Blatt GJ. 2009. Decreased GABAA receptors and benzodiazepine binding sites in the anterior cingulate cortex in autism. Autism Res. 2009 Aug;2(4):205-19. 
  28. Emily L. Williams, Manuel F. Casanova. Autism and dyslexia: a spectrum of cognitive styles as defined by minicolumnar morphometry. Med Hypotheses. 2010 Jan;74(1):59-62. Epub 2009 Aug 26 
  29. Manuel F. Casanova, Ayman S. El-Baz, Jay Giedd, Judith M. Rumsey, Andrew E. Switala. Increased white matter gyral depth in dyslexia: implications for corticocortical connectivity. Journal of Autism and Developmental Disorders. 2010 Jan;40(1):21-9. Epub 2009 Jul 16. 
  30. Manuel F. Casanova, Ayman El-Baz, Eric Vanbogaert, Praveen Narahari, Andrew Switala. 2010. A topographic study of minicolumnar core width by lamina comparison between autistic subjects and controls: possible minicolumnar disruption due to an anatomical element in-common to multiple laminae. Brain Pathology Mar;20(2):451-8. Epub 2009 Jul 8 
  31. C Lintas, C, Sacco R, Garbett K, Mirnics K, Militerni R,Bravaccio C, Curatolo P, Manzi B, Schneider C, Melmed R, Elia M, Pascucci T, Puglisi-Allegra S, Reichelt K-L and AM Persico. 2009. Involvement of the PRKCB1 gene in autistic disorder: significant genetic association and reduced neocortical gene expression. Molecular Psychiatry 14, 705–718 
  32. Casanova MF, El-Baz A, Mott M, Mannheim G, Hassan H, Fahmi R, Giedd J, Rumsey JM, Switala AE, Farag A. 2009. Reduced Gyral Window and Corpus Callosum Size in Autism: Possible Macroscopic Correlates of a Minicolumnopathy. J Autism Dev Disord. Jan 16. [Epub ahead of print] 
  33. Abuhatzira L, Shemer R, Razin A. MeCP2 involvement in the regulation of neuronal alpha-tubulin production.Hum Mol Genet. 2009 Apr 15;18(8):1415-23. Epub 2009 Jan 27. 
  34. Yip, Jane, Soghomonian, Jean-Jacques and Gene J. Blatt. 2008. Increased GAD67 mRNA Expression in Cerebellar Interneurons in Autism: Implications for Purkinje Cell Dysfunction Journal of Neuroscience Research 86:525–530. 
  35. Whitney, Elizabeth R., Kemper, Thomas L., Bauman, Margaret L., Rosene, Douglas L. & Gene J. Blatt. 2008. Cerebellar Purkinje Cells are Reduced in a Subpopulation of Autistic Brains: A Stereological Experiment Using Calbindin-D28k. Cerebellum 7:406–416. 
  36. Whitney, Elizabeth R., Kemper, Thomas L., Rosene, Douglas L., Bauman, Margaret L. & Gene J. Blatt. 2008. Calbindin-D28k is a more reliable marker of human Purkinje cells than standard Nissl stains: A stereological experiment. Journal of Neuroscience Methods 168:42–47. 
  37. Palmieri L, Papaleo V, Porcelli V, Scarcia P, Gaita L, Sacco R, Hager J, Rousseau F, Curatolo P, Manzi B, Militerni R, Bravaccio C, Trillo S, Schneider C, Melmed R, Elia M, Lenti C, Saccani M, Pascucci T, Puglisi-Allegra S, Reichelt KL, Persico AM. 2008. Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. Mol Psychiatry. Jul 8. [Epub ahead of print] 
  38. Maussion G, Carayol j, Lepagnol-Bestel A-M, Tores F, Loe-Mie T, Milbreta U, Rousseau F, Fontaine K, Renaud J, Moalic J-M, Philippi A, Chedotal A, Gorwood P, Ramoz N, Hager j and Michel Simonneau2008. Convergent evidence identifying MAP/microtubule affinity regulating kinase 1 (MARK1) as a susceptibility gene for autism. Human Molecular Genetics 17:1-11  
  39. Kawther Abu-Elneel, Tsunglin Liu, Francesca S Gazzaniga, Yuhei Nishimura, Dennis P Wall, Daniel H Geschwind, Kaiqin Lao, Kenneth S Kosik. 2008. Heterogeneous Dysregulation of microRNAs across the Autism Spectrum. Neurogenetics 9:153-161.  
  40. Lepagnol-Bestel AM, Maussion G, Boda B, Cardona A, Iwayama Y, Delezoide AL, Moalic JM, Muller D, Dean B, Yoshikawa T, Gorwood P, Buxbaum JD, Ramoz N, Simonneau M. 2008. SLC25A12 expression is associated with neurite outgrowth and is upregulated in the prefrontal cortex of autistic subjects. Mol Psychiatry. 2008 Apr;13(4):385-97. Epub 2008 Jan 8. 
  41. Van Kooten, IAJ, Palmen, SJMC, von Cappeln, P; Steinbusch, HWM, Korr, H, Heinsen, H, Hof, PR, van Engeland, H & C Schmitz. 2008. Neurons in the fusiform gyrus are fewer and smaller in autism. Brain 131:987-999. 
  42. Schmitz C & Rezaie P. 2008. The neuropathology of autism: where do we stand? Neuropathol Appl Neurobiol. 34(1):4-11. 
  43. Kulesza, RJ & K Mangunay. 2008. Morphological features of the medial superior olive in autism. Brain Res. Brain Res. 2008 Jan 14; [Epub ahead of print] 
  44. Evans, TA, Siedlak, SL, Lu, L, Fu, X, Wang, Z, McGinnis, WR, Fakhoury, E, Castellan, RJ, Hazen, SL, Walsh, WJ, Lewis, AT, Salomon, RG, Smith, MA, Perry G & X. Zhu 2008. The Autistic Phenotype Exhibits a Remarkably Localized Modification of Brain Protein by Products of Free Radical-Induced Lipid Oxidation    American Journal of Biotechnology and Biochemistry 4 (2): 61-72. 
  45. Sajdel-Sulkowska, EM, Lipinski, B, Windom, H, Audhya, T and W McGinnis. 2008. Oxidative Stress in Autism: Elevated Cerebellar 3-nitrotyrosine Levels. American Journal of Biochemisty and Biotechnology 4:73-84. 
  46. López-Hurtado, Edith and Jorge J. Prieto. 2008. A Microscopic Study of Language-Related Cortex in Autism American Journal of Biochemisty and Biotechnology 4:130-145. 
  47. Pardo, CA and Charles G. Eberhart. 2007. The Neurobiology of Autism. Brain Pathology 17:434-447. 
  48. Campbell, Daniel B.; D’Oronzio, Rosanna; Garbett, Krassi; Ebert, Philip J.; Mirnics, Karoly; Levitt, Pat and Antonio M. Persico. 2007. Disruption of Cerebral Cortex MET Signaling in Autism Spectrum Disorder. Ann Neurol 62:243-250. 
  49. Gregg JP, Lit L, Baron CA, Hertz-Picciotto I, Walker W, Davis RA, Croen LA, Ozonoff S, Hansen R, Pessah IN, Sharp FR. Gene expression changes in children with autism. Genomics. 2008 Jan;91(1):22-9. Epub 2007 Nov 14. 
  50. Kennedy, DP, Semendeferi, K and E Courchesne. 2007. No reduction of spindle neuron number in frontoinsular cortex in autism. Brain and Cognition 64:124–129. 
  51. El-Baz, A., Casanova, MF, Gimel’farb, G., Mott,M. and Andrew E. Switwala 2007. A new image analysis approach for automatic classification of autistic brains. IEEE 352-355.  
  52. Fahmi, R., El-Baz, AS, El Munim, HE, Farag, AA and MF Casanova. 2007. Classification techniques for autistic vs. typically developing brain using MRI data. IEEE 1348-1351. 
  53. Pardo, CA and CG Eberhart. 2007. The Neurobiology of Autism (Symposium: Neurobiology of Autism). Brain Pathology, 17:434-447. 
  54. London, E. 2007. The Role of the Neurobiologist in Redefining the Diagnosis of Autism. (Symposium: Neurobiology of Autism). Brain Pathology, 17:408-411. 
  55. Casanova, MF. 2007. The Neurobiology of Autism (Symposium: Neurobiology of Autism). Brain Pathology. 17:422-33. 
  56. Haroutunian, V and J Pickett. 2007. Autism Brain Tissue Banking (Symposium: Neurobiology of Autism). Brain Pathology, 17:412-421.
  57. Halladay, A, Demetrikopoulos, MK and J Pickett. Autism Brain Tissue Research: Findings Presented at the 2006 IMFAR meeting. Autism-Asperger’s Digest. March-April 2007. 
  58. Yip, J, Soghomonian, J-J & J. Blatt. 2007. Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiology implications. Acta Neuropathol. Jan 18; [Epub ahead of print]. 
  59. Brimacombe M, Pickett J, Pickett R. 2007. Autism Post-Mortem Neuroinformatic Resource: The Autism Tissue Program (ATP) Informatics Portal. J Autism Dev Disord Mar 37(3):574-9.  
  60. Eberhart, C, Copeland, J & T Abel. 2006. Brief Report: S6 Ribosomal Protein Phosphorylation in Autistic Frontal Cortex and Cerebellum: a Tissue Array Analysis. J Autism Dev Disord. 36:1131-1136. 
  61. J. Hutsler, Tiffany Love, and Hong Zhang. 2006. Histological and Magnetic Resonance Imaging Assessment of Cortical Layering and Thickness in Autism Spectrum Disorders. Biological Psychiatry Mar 30; [Epub ahead of print] 
  62. Nagarajan R, Hogart AR, Gwye Y, Martin MR & JM LaSalle. 2006. Reduced MeCP2 Expression is Frequent in Autism Frontal Cortex and Correlates with Aberrant     MECP2 Promoter Methylation. Epigenetics 1:4, 172-182. 
  63. Buxhoeveden, DB, Semendeferi, K, Buckwalter, J, Schenker, N, Switzer, R and E Courchesne. 2006. Reduced minicolumns in the frontal cortex of patients with autism. Neuropathology and Applied Neurobiology 32:1-9.  
  64. Eberhart CG, Copeland J, Abel TW. 2006. Brief Report: S6 Ribosomal Protein Phosphorylation in Autistic Frontal Cortex and Cerebellum: a Tissue Array Analysis. J Autism Dev Disord. 2006 Jul 15; [Epub ahead of print] 
  65. Casanova MF. Neuropathological and genetic findings in autism: the significance of a putative minicolumnopathy. Neuroscientist. 2006 Oct;12(5):435-41. 
  66. Casanova MF, van Kooten IA, Switala AE, van Engeland H, Heinsen H, Steinbusch HW, Hof PR, Trippe J, Stone J, Schmitz C. 2006. Minicolumnar abnormalities in autism. Acta Neuropathol (Berl). Sep;112(3):287-303. Epub Jul 4. 
  67. CM Schumann and DG Amaral. 2006. Stereological analysis of amygdala neuron number in autism J. Neuroscience 26: 7674-7679. 
  68. Pickett et.al. 2006. 1998-2002 update on causes of death in autism [letter]. Journal of Autism and Developmental Disorders. Feb;36(2):287-8 
  69. Akbarian S, Huang HS. 2006. Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res Brain Res Rev 2006 Jun 5;[epub ahead of print]. 
  70. Martchek M, Thevarkunnel S, Bauman M, Blatt G, Kemper T. (2006) Lack of evidence of neuropathology in the locus coeruleus in autism. Acta Neuropathol (Berl). 111:497-9. 
  71. Pardo, CA, Vargas, DL & AW Zimmerman. 2005. Immunity, neuroglia and neuroinflammation in autism. International Review of Psychiatry, December 2005; 17(6): 485–495.  
  72. Pickett, J. & E. London. 2005. The Neuropathology of Autism: A Review. Journal of Neuropathology and Experimental Neurology. 64(11):1-11.  
  73. Schmitz C, van Kooten IA, Hof PR, van Engeland H, Patterson PH, Steinbusch HW Autism: neuropathology, alterations of the GABAergic system, and animal models. Int Rev Neurobiol. 2005;71:1-26. 
  74. Blatt, G.J. (2005) GABAergic cerebellar system in autism: A neuropathological and developmental perspective. Int. Rev. Neurobiol. 71:167-178. 
  75. Schumann CM and Amaral DG. Stereological estimation of the number of neurons in the human amygdaloid complex. J Comp Neurol. 2005 Oct 31;491(4):320-9. 
  76. Ray MA, Graham AJ, Lee M, Perry RH, Court JA, Perry EK. 2005. Neuronal nicotinic acetylcholine receptor subunits in autism: an immunohistochemical investigation in the thalamus. Neurobiol Dis. Aug;19(3):366-77. 
  77. Redcay E & Courchesne E. When is the brain enlarged in autism? A meta-analysis of all brain size Reports. Biol Psychiatry. 2005 Jul 1;58(1):1-9. 
  78. Vargas D.L., Nascimbene, C. Krishnan, C. Zimmerman, A.W. and Pardo, C.A. 2005. Increased neuroglial activation and neuroinflammation in the brain of patients with autism. Annals of Neurology 57(1):67-81. 
  79. Samaco RC, Hogart A, Lasalle JM. 2005. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum Mol Genet. Feb 15;14(4):483-92. Epub 2004 Dec 22.  
  80. Samaco RC, Nagarajan RP, Braunschweig D, LaSalle JM. (2004) Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders. Hum Mol Genet. 2004 Mar 15;13(6):629-39. 
  81. Courchesne E. 2004. Brain Development in autism: early overgrowth followed by premature arrest of growth. Ment Retard Dev Disabil Res Rev.10(2):106-11. 
  82. Jiang, Y-H., Sahoo, T., Michaelis, R.C., Bercovich, D., Bressler, J., Kashork, C.D., Liu, Q., Shaffer, L.G., Schroer,R.J., Stockton, D.W., Spielman, R.S., Stevenson, R.E. & Beaudet; A.L. 2004. A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. Am J Med Genet A. Nov 15;131(1):1-10. 
  83. Junaid, M.A., Kowal, D., Barua, M., Pullarkat, P.S., Skower-Brooks, S., and Pullarkat, R.K. 2004 Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor. Am J Med Genet 131A:11–17.   
  84. Martin-Ruiz CM, Lee M, Perry RH, Baumann M, Court JA, Perry EK. 2004. Molecular analysis of nicotinic receptor expression in autism. Brain Res Mol Brain Res. Apr 7;123(1-2):81-90. 
  85. Mukaetova-Ladinska EB, Arnold H, Jaros E, Perry R, Perry E. 2004. Depletion of MAP2 expression and laminar cytoarchitectonic changes in dorsolateral prefrontal cortex in adult autistic individuals. Neuropathol Appl Neurobiol. 2004 Dec;30(6):615-23. 
  86. Palmen SJ, van Engeland H, Hof PR, Schmitz C. 2004. Neuropathological findings in autism. Brain. 2004 Dec;127(Pt 12):2572-83. Epub 2004 Aug 25. 
  87. Lee DA, Lopez-Alberola R, Bhattacharjee M. Childhood autism: a circuit syndrome? Neurologist. 2003 Mar;9(2):99-109. 
  88. Casanova MF, Buxhoeveden D, Gomez J. 2003 Disruption in the inhibitory architecture of the cell minicolumn: implications for autism. Neuroscientist Dec;9(6):496-507. 
  89. Fatemi SH, Halt AR, Stary JM, Kanodia R, Schulz SC, Realmuto GR. 2002. Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol Psychiatry. Oct 15;52(8):805-10. 
  90. Perry EK, Lee ML, Martin-Ruiz CM, Court JA, Volsen SG, Merrit J, Folly E, Iversen PE, Bauman ML, Perry RH, Wenk GL. 2001. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am J Psychiatry. 2001 Jul;158(7):1058-66. 
  91. Fatemi SH, Stary JM, Halt AR, Realmuto GR. 2001. Dysregulation of Reelin and Bcl-2 proteins in autistic cerebellum. J Autism Dev Disord. 2001 Dec;31(6):529-35. 
  92. Gene J. Blatt, G.J., Fitzgerald, C.M., Guptill, J.T., Booker, A.B., Kemper, T.L. & Bauman, M.L. (2001). Density and distribution of hippocampal neurotransmitter receptors in autism: An autoradiographic study. Journal of Autism and Developmental Disorders 31: 537-544.    
  93. Junaid, M.A. & Pullarkat, R. K. (2001). Proteomic approach for the elucidation of biological defects in autism. Journal of Autism and Developmental Disorders 31: 557-560.  
  94. Hemby, S.E., Sanchez, M.M. & Winslow, J.T. (2001). Functional Genomics Approaches to A Primate Model of Autistic Symptomology. Journal of Autism and Developmental Disorders 31: 551-556. 
  95. Purcell, A.K., Jeon, O. & Pevsner, J. (2001). The Abnormal Regulation of Gene Expression in Autistic Brain. Journal of Autism and Developmental Disorders. 31: 545-550.  
  96. Amy E. Purcell, Mary Margaret Rocco, Jennifer A. Lenhart, Karim Hyder, Andrew W. Zimmerman, and Jonathan Pevsner. 2001. Assessment of neural cell adhesion molecule (NCAM) in autistic serum and postmortem brain. Journal qf Autism and Developmental Disorder 31, 2:183-194, 2001. 
  97. Schumann, C.M., Buonocore, M.H. & Amaral, D.G. (2001). MRI of the Post-Mortem Autistic Brain Journal of Autism and Developmental Disorders 31: 561-569.      
  98. Shavelle, R., Strauss, R. and Pickett, J. (2001). Causes of Death in Autism. Journal of Autism and Developmental Disorders 31: 569-576.   
  99. Shavelle, R.M., Strauss, D.J. & Pickett, J.A. (2001). Listing of causes of death of persons with autism in California 1983-1987. Website: http://www.LifeExpectancy.com/autism.html.  

100. Pickett, J. (2001) Current Investigations in Autism Brain Tissue Research. Journal of Autism and Developmental Disorders 31: 521-527.